Business / Finance

RSS

Anesthesia Business Consultants unveils newest tool, F1RSTAnalytics at ASA Annual Convention

Anesthesia Business Consultants (ABC) announces today that it will unveil its newest tool, F1RSTAnalytics™ at the ASA Annual Convention in San Francisco, CA, October 12-16th. F1RSTAnalytics offers "Insight at Your Fingertips."

9 Oct 2013

AquaBased introduces new eco-friendly water-based adhesive for plastic-to-plastic bonding

AquaBased Technologies, a division of ADM Tronics Unlimited, Inc. (OTCQB:ADMT), has introduced AquaTack™ 7001-PAA, a new, eco-friendly, water-based adhesive specifically designed for use in flexographic presses and other roller coater applicators for the lamination of virtually any type of low surface energy plastic films as well as for other plastic-to-plastic bonding applications.

9 Oct 2013

NeuroVigil opens satellite research lab at NASA to develop assistive technologies for ALS

NeuroVigil, Inc. is setting to collaborate with a number of partners in the Silicon Valley where it is opening a satellite research laboratory at NASA Research Park in Mountain View, CA, to develop assistive technologies for individuals suffering from ALS and other conditions affecting the central nervous system.

9 Oct 2013

Software crash in first days viewed as root cause of exchange delays

The New York Times reports that a major software component crashed under the pressure posed by millions of visitors last week to the federal online insurance marketplace. Still, other technical issues beyond traffic also are at work, and some insurers say they are getting faulty and incomplete data from the new U.S.-run health exchange.

9 Oct 2013

New booklet helps researchers decide about conducting clinical trials in Asia-Pacific region

A new booklet from Theorem Clinical Research is now available to help researchers at medical device companies decide if they want to conduct clinical trials in the Asia-Pacific region, and, if so, in what countries.

9 Oct 2013

Nuventra launches innovative software platform for conducting population PK analyses

Nuventra Pharma Sciences, a specialty pharmaceutical consulting firm with global reach, is pleased to announce the launch and availability of an innovative software platform called Darwin for conducting population pharmacokinetic (PK) analyses based on a genetic algorithm paradigm.

9 Oct 2013

Healios K.K. successfully raised its target capital of 3 billion JPY (USD $30.6 million)

Healios K.K. (Headquarters: Tokyo, Japan; President and CEO: Hardy TS Kagimoto M.D.), a Japanese bioventure company at the forefront of developing innovative therapies utilizing human induced pluripotent stem cell (hiPSC) technology, is pleased to announce that it has successfully raised its target capital of 3 billion JPY (USD $30.6 million).

9 Oct 2013

Saint Luke's Health System launches doxo to enhance quality of services

Saint Luke's Health System and doxo today announced Saint Luke's Health System has launched doxo across all ten of its hospitals to expand patients' electronic access to their billing information.

9 Oct 2013

Francisco Partners invests in NexTech

Francisco Partners, a leading technology-focused private equity firm, today announced a strategic investment in NexTech, a leading provider of fully integrated electronic medical records, practice management, and marketing software solutions for specialty physician practices. Closing is subject to customary conditions, including Hart-Scott-Rodino clearance.

9 Oct 2013

Ramsell partners with Alameda County to provide pharmacy benefits management services

Ramsell, a leading provider of innovative solutions for organizations that serve the underserved, today announced a new partnership with Alameda County Behavioral Health Care Services to provide pharmacy benefits management services to more than 900 low-income mental health patients.

9 Oct 2013

Laborie acquires UroMed's pelvic muscle rehabilitation business

Laborie Medical Technologies, Inc., a portfolio company of Audax Group, announced it has completed the acquisition of UroMed Technology, Inc.'s pelvic muscle rehabilitation business.

9 Oct 2013

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Quintiles and the Muscular Dystrophy Association (MDA) today announced a new partnership to develop and implement the U.S. Neuromuscular Disease Registry, a patient registry that will play an important role in determining effective treatments for people with muscular dystrophy and related muscle diseases.

9 Oct 2013

Bariatric Advantage announces new decaffeinated version of Pro Joe Magnifico Mocha

Bariatric Advantage today announced that bariatric patients now have another option to increase their daily protein intake with the new decaffeinated version of Pro Joe Magnifico Mocha.

9 Oct 2013

AdvantEdge Healthcare launches QualityEdge information capture service

AdvantEdge Healthcare Solutions, one of the nation's leading providers of medical billing, practice management, and coding services for specialty physicians, hospitals, and surgery centers, is launching its QualityEdgeSM information capture service, which allows physicians and other providers to easily capture data that would otherwise require paper notes or the use of an EMR.

9 Oct 2013

Net income of Biomet increased 33.8% to $80.8M in first quarter of 2014

Biomet, Inc. announced today financial results for its first quarter ended August 31, 2013.

9 Oct 2013

Boehringer Ingelheim’s interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.

8 Oct 2013

J&J's Janssen Buys Rights To Hepatitis C Compound From GSK

...

8 Oct 2013

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

...

8 Oct 2013

MedShape closes $11 million in new financing

MedShape, Inc., the industry leader in shape memory orthopedic devices, today announced the closing of $11 million in new financing. The investment will help drive further development and commercialization of pipeline products, including the full market release of the Eclipse Soft Tissue Anchor, MedShape's newest shape memory fixation device for soft tissue repair.

8 Oct 2013

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Eddingpharm continued to aggressively build its product portfolio by inking another cancer agreement, this time with Immutep. In this latest agreement, Eddingpharm was granted exclusive rights to develop and market ImmuFact® IMP321 in mainland China, Hong Kong, Macau, and Taiwan.

7 Oct 2013

Business / Finance

Anesthesia Business Consultants unveils newest tool, F1RSTAnalytics at ASA Annual Convention

AquaBased introduces new eco-friendly water-based adhesive for plastic-to-plastic bonding

NeuroVigil opens satellite research lab at NASA to develop assistive technologies for ALS

Software crash in first days viewed as root cause of exchange delays

New booklet helps researchers decide about conducting clinical trials in Asia-Pacific region

Nuventra launches innovative software platform for conducting population PK analyses

Healios K.K. successfully raised its target capital of 3 billion JPY (USD $30.6 million)

Saint Luke's Health System launches doxo to enhance quality of services

Francisco Partners invests in NexTech

Ramsell partners with Alameda County to provide pharmacy benefits management services

Laborie acquires UroMed's pelvic muscle rehabilitation business

Quintiles and MDA partner to develop U.S. Neuromuscular Disease Registry

Bariatric Advantage announces new decaffeinated version of Pro Joe Magnifico Mocha

AdvantEdge Healthcare launches QualityEdge information capture service

Net income of Biomet increased 33.8% to $80.8M in first quarter of 2014

Boehringer Ingelheim’s interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

J&J's Janssen Buys Rights To Hepatitis C Compound From GSK

Clinical Genomics Nabs Enterix, Aims To Launch New Bowel Cancer Blood Test

MedShape closes $11 million in new financing

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News